Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levosalbutamol vs Racemic Salbutamol in Persistent Asthmatics
NCT00830882Phase 4Withdrawn
- Sponsor
- University of Dundee
- Start
- Jan 2009
- Primary completion
- Jan 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of levalbuterol in asthma (3 arms), sponsored by University of Dundee. Primary endpoint: Methacholine challenge PC20 at 2 weeks. Planned start Jan 2009; status: withdrawn.
02
Drugs
levalbuterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00830882.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00830882.